Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. - Wikidata - wikimedia - TriplyDB

Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes.

Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes.

http://www.wikidata.org/entity/Q43001906

about

Standards of medical care in diabetes--2012 Coming of age: the artificial pancreas for type 1 diabetes Insulin delivery methods: Past, present and future Integrated insulin pump therapy with continuous glucose monitoring for improved adherence: technology update The rise of multiple imputation: a review of the reporting and implementation of the method in medical research Insulin therapy for the treatment of type 1 diabetes during pregnancy Type 1 diabetes Closed-loop insulin delivery for treatment of type 1 diabetes Clinical requirements for closed-loop control systems.Technology to optimize pediatric diabetes management and outcomes Continuous glucose monitoring: evidence and consensus statement for clinical use An Overview of Insulin Pumps and Glucose Sensors for the Generalist Insulin Aspart in the Management of Diabetes Mellitus: 15 Years of Clinical Experience Type 1 diabetes through the life span: a position statement of the American Diabetes Association Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies Standards of medical care in diabetes--2013 Outcome Measures for Artificial Pancreas Clinical Trials: A Consensus Report Circadian variability of insulin sensitivity: physiological input for in silico artificial pancreas.Continuous glucose monitoring: current use and future directions Design and Evaluation of a Robust PID Controller for a Fully Implantable Artificial Pancreas.Compact and Thermosensitive Nature-inspired Micropump.Insulin therapy and hypoglycemia.In silico design of optimal ratio for co-administration of pramlintide and insulin in type 1 diabetes.The accuracy benefit of multiple amperometric glucose sensors in people with type 1 diabetes Closed-loop glucose control: psychological and behavioral considerations Current concepts in blood glucose monitoring Current application of continuous glucose monitoring in the treatment of diabetes: pros and cons Italian contributions to the development of continuous glucose monitoring sensors for diabetes management.Factors predictive of severe hypoglycemia in type 1 diabetes: analysis from the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized control trial dataset Implantable batteryless device for on-demand and pulsatile insulin administration The Transformation of Diabetes Care Through the Use of Person-Centered Data The use of an automated, portable glucose control system for overnight glucose control in adolescents and young adults with type 1 diabetes.Adherence of self-monitoring of blood glucose in persons with type 1 diabetes in Sweden.Clinical Use of Continuous Glucose Monitoring in Adults with Type 1 Diabetes.Targeting innate immunity to downmodulate adaptive immunity and reverse type 1 diabetes.CGM, Pregnancy, and Remote Monitoring Continuous Glucose Monitoring and Global Reimbursement: An Update.The JDRF CCTN CGM TIME Trial: Timing of Initiation of continuous glucose Monitoring in Established pediatric type 1 diabetes: study protocol, recruitment and baseline characteristics Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data.Impact of continuous glucose monitoring on quality of life, treatment satisfaction, and use of medical care resources: analyses from the SWITCH study

P2860

Q24632533-2CB0E846-325F-4C52-B577-EAAF60F32271 Q26745886-37CEBE6A-A675-4872-91A0-2A1B518F7A1D Q26750895-4BC3CFFB-2677-4E5B-8D33-3A7B790FE8F5 Q26785492-EBE4D440-7B58-4526-BE69-E66ADACD8464 Q26828889-875D6BE5-443A-458A-BB8D-3ACDBF0EAE1D Q26829977-68F0614B-1670-47B3-AA4E-F9C9592C532A Q27000491-F7BF4DAC-214F-492F-A4BB-77ACDDDA3BCF Q27008127-1A8D2E0B-98BE-4297-825E-0C4A8A7CA482 Q27014883-FF9AA202-20AE-4F4A-930B-AFEF769D17F3 Q27022145-8A378B32-794E-4838-BBD4-E3771FB37389 Q27022628-133E8285-4C02-4D5F-BA64-86E8B071A782 Q28076381-9AF023F1-5F6A-48F3-BEC3-980A41C27DC9 Q28085428-53699FA8-8722-4FCD-BC6C-F562F1411618 Q28242092-4480B12D-8DA2-4293-AC00-AE871C329AB4 Q28741005-910C5EE7-BD72-4EFF-8DE8-26F2F6448D35 Q29620309-0491BBFC-BF5C-45DE-840C-9462A112FBB8 Q30276532-C97ECACE-559F-466C-AAA2-8C863FA4B657 Q30301086-EAA17D06-8E57-47A8-8CA3-C0662E30A6E8 Q30354773-20160651-933B-4EF7-92B8-BFEF63BD6643 Q30370001-266485FB-E0C3-4047-A28D-D7039C605FC6 Q30370686-F416962B-E27B-4C06-95A2-941E5F04A005 Q30409109-11C67F59-C0AE-4A5F-B271-8E7B38D977BD Q30410405-7EEAA4EA-69D6-4E86-94BF-DA2E16D70420 Q30421548-D66F4773-4E3A-4EB0-ACB5-7C3B47CF5EC0 Q30424290-F0040423-84AD-43EE-876F-CD88BEFAD89F Q30437091-9553C5F5-1F8E-4882-B696-00BF7A4B4FC1 Q30455250-D18BCAE7-5987-43F9-AD1A-BA4D11250B32 Q30458979-94A5ED25-0B0A-4E5C-8174-6DDEFFC9C463 Q30498210-12598B82-C350-43B2-83EA-442AF64EDFB3 Q30846603-6AB5EC1B-92B2-4F65-9B68-B741CB4B0508 Q31009470-28FED989-FFDC-45D7-8834-529B03447B09 Q33439009-B5DA57B6-6B5F-4D64-98F6-8AE6F734AFD2 Q33552684-3701CB73-D9B1-4EAC-917B-203A59F30BA2 Q33727481-3CFC5203-B31E-4987-8D99-CF3523A3BB25 Q33739020-BD0AE386-5DBB-47C9-A889-EF953559FB94 Q33786126-D20BA258-06B1-4FF6-833D-E89605A4A020 Q33786148-43494819-EA28-47F9-A30D-304B2072AC1F Q33945186-40E306FB-C5D2-4A82-AB1C-1555EF1B76A4 Q33954163-F2C0674A-3CA4-44E7-B1AB-FE173FB873DD Q34252778-D2944DAB-F003-4F06-8B27-7600FBF58878

P2860

Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes.

http://www.wikidata.org/entity/Q43001906

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh-hant

name

Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes.

@en

Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes.

@nl

type

label

Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes.

@en

Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes.

@nl

prefLabel

Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes.

@en

Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes.

@nl

P1433

Q43001906-1E047E9D-2F64-49C4-8DD8-A1DB8A531933

P1476

Q43001906-44BD91C1-583E-4379-A93A-D1E887BD2866

P2093

Q43001906-025A7954-524A-4D0E-B58D-4D05DF26E6BE

Q43001906-0DF24227-AA06-48C5-BD94-07A691F5136C

Q43001906-3F740A9A-40F1-425A-9AF9-F7AECAAB057F

Q43001906-4A14DF4B-0556-408B-8D91-B565FAADBEBB

Q43001906-5A691411-2B7B-4A68-A49C-57977A315341

Q43001906-713DE97B-1CC6-41A8-9FD5-208CCADB661F

Q43001906-B934CCF1-3800-4810-94E2-AEF71FC942BF

Q43001906-CB8A87C2-20A7-4BBA-8298-5C11B68EEA19

Q43001906-D09DDD9E-D014-4830-BF8B-84B6CA3B17A1

Q43001906-D50D0CD6-58E1-4B31-8065-A7853859D3E9

P304

Q43001906-6D8D6C1F-D819-4C15-B924-F01290820D93

P31

Q43001906-1B4D88ED-E406-4C5E-A8C2-DD7C9D118F19

P356

Q43001906-3DB1C2F0-3135-47E5-9101-7AB7FCDF0957

P407

Q43001906-630C3692-B8C0-4336-B0D3-4427F0A2BE80

P433

Q43001906-5CE2109E-B147-4F15-AFD8-6DA46CF08C59

P478

Q43001906-270EB644-E81F-4563-B1D3-B2481351CD5C

P50

Q43001906-BA229087-FF88-4666-A33D-537165EDEAD1

Q43001906-FF6DB937-2C3E-473F-95D9-90431E218421

P577

Q43001906-D1A48C5F-4092-4351-8E65-3DE4F1DB3962

P698

Q43001906-7F02E019-F59A-4A94-900F-FDCB04A9E033

P921

Q43001906-87957974-8914-4BB6-8742-0DA8943EDC8C

Q43001906-BD6089CC-6094-45AC-BE7B-6AEC05F19B76

P356

P1433

The New England Journal of Medicine

P1476

Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes.

@en

P2093

Andrew Ahmann

http://www.w3.org/2001/XMLSchema#string

Bruce A Perkins

http://www.w3.org/2001/XMLSchema#string

Carol Joyce

http://www.w3.org/2001/XMLSchema#string

George Dailey

http://www.w3.org/2001/XMLSchema#string

John B Welsh

http://www.w3.org/2001/XMLSchema#string

Michael A Wood

http://www.w3.org/2001/XMLSchema#string

Richard M Bergenstal

http://www.w3.org/2001/XMLSchema#string

STAR 3 Study Group

http://www.w3.org/2001/XMLSchema#string

Stephen N Davis

http://www.w3.org/2001/XMLSchema#string

Steven M Willi

http://www.w3.org/2001/XMLSchema#string

P304

311-320

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA1002853

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

363

http://www.w3.org/2001/XMLSchema#string

P50

William V Tamborlane

P577

2010-06-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20587585

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes